Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening.
about
Ciclesonide versus placebo for chronic asthma in adults and childrenCiclesonide versus other inhaled steroids for chronic asthma in children and adultsCiclesonide uptake and metabolism in human alveolar type II epithelial cells (A549)Metabolism of ciclesonide in the upper and lower airways: review of available data.Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma.Comparison of intranasal ciclesonide, oral levocetirizine, and combination treatment for allergic rhinitisThe efficacy of systemic corticosteroids in treatment of respiratory tract infections during hajj 2012.Ciclesonide for the treatment of asthma.Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study.Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trialRisk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaNew anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.Ciclesonide in persistent asthma: the evidence of its therapeutic value.Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma.Novel therapeutic interventions for allergic rhinitis.Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.Oral inhalation therapy: meeting the challenge of developing more patient-appropriate devices.Outcomes associated with inhaled corticosteroid use in asthma and COPD: an update.Ciclesonide and the treatment of asthma.Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Chronopharmacology of roflumilast: a comparative pharmacokinetic study of morning versus evening administration in healthy adults.Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.Population pharmacokinetics and pharmacodynamics of ciclesonide.Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
P2860
Q24243016-6D326C2A-F6F3-4C85-ADA2-4B71EBC971B3Q24243159-B4F75796-C31F-494E-B23B-576697A0B8E1Q33300580-1CB30DA2-AC29-40FE-98AC-DD85E247EF1CQ33855461-766163BE-9255-44B5-A52D-6773C68E016EQ34623848-EA4446A5-32FA-4F93-B31B-A94B3BE3FC5AQ35123917-CC716443-6A90-4925-86CB-BB593EF9CAA1Q35124284-D9C33E85-A78F-488E-9DE3-A8CB7666C860Q35166788-2C01308B-51E0-4E38-B865-53A9D5E1FF4CQ35216003-D611086C-C885-434F-A22C-09A9519A4048Q35225926-CBAE36EA-22D9-4C3F-9CE4-54338EEB2E82Q35554841-0510B0CF-2CAA-4921-8388-4CF1CDF7C511Q35610011-E96268D4-FF9D-4933-94F3-4C64EF8BF216Q35766467-87B7A7CB-E701-4649-8500-E5D29A28FA89Q35842492-43E61768-1B58-4AFB-8638-C29F323B775FQ35876418-E879A8FC-7B9B-4518-ABEB-D263FC555AC7Q36005008-8B64BDCD-E46E-4E35-9A40-F0B91614A5FFQ36128735-61CC255F-2DFA-42F1-AA23-9E1D3917F8F6Q36613943-C365887C-28DA-40CA-8423-EFEF622849FCQ36654345-5335B5DD-A064-4E6F-B96E-4559F3FAF754Q36782563-4D3F46B9-2088-47D7-96E0-00D620A6AB25Q37418071-6D8FE8D9-ED3A-4879-A0B0-BD42E13CB95EQ37609363-2240EF55-A634-4D7F-9D2E-88C6AEEDB3B1Q37681579-1982B948-D52B-4963-BF40-09246193F8F7Q38130512-48AED6B5-C600-4067-8BAC-DD1BD82C54F0Q38947467-B9903CDF-8784-468B-93EE-ED90E8713E51Q42850046-73F3F4BC-EE56-4B1B-AE0C-05143F335ABDQ42854436-539343AA-3DFF-4141-9693-602CEA271B60Q44424374-33FAD4B5-050F-4996-A3B1-17B89CBD6DA1Q45221731-D3C8A1DF-E070-4247-B871-946983AAEB18Q46988680-FA3DCD6A-E249-434A-97E8-3751B14BCCAF
P2860
Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Treatment of asthma by the inh ...... her in the morning or evening.
@en
Treatment of asthma by the inh ...... her in the morning or evening.
@nl
type
label
Treatment of asthma by the inh ...... her in the morning or evening.
@en
Treatment of asthma by the inh ...... her in the morning or evening.
@nl
prefLabel
Treatment of asthma by the inh ...... her in the morning or evening.
@en
Treatment of asthma by the inh ...... her in the morning or evening.
@nl
P2093
P1476
Treatment of asthma by the inh ...... her in the morning or evening.
@en
P2093
P304
P356
10.1183/09031936.01.00099701
P577
2001-06-01T00:00:00Z